Journal of Medicinal Chemistry
Article
validation, and mechanism of action. Int. J. Parasitol. 1999, 29, 833−
837.
(26) Gillmor, S. A.; Craik, C. S.; Fletterick, R. J. Structural
determinants of specificity in the cysteine protease cruzain. Protein
Sci. 1997, 6, 1603−1611.
(27) Teague, S. J.; Davis, A. M.; Leeson, P. D.; Oprea, T. The design
of leadlike combinatorial libraries. Angew. Chem., Int. Ed. 1999, 38,
3743−3748.
(28) Hu, Q.; Xia, Z.; Fan, L.; Zheng, J.; Wang, X.; Lv, X. Copper-
catalyzed one-pot synthesis of 2H-1,4-benzoxazin-3-(4H)-ones from 2-
(o-haloaryloxy)acyl chlorides and primary amines. Arch. Org. Chem.
2012, 2012, 129−142.
(29) Meng, X. Q.; Zhang, J. J.; Liang, X. M.; Zhu, W. J.; Dong, Y. H.;
Wu, X. M.; Huang, J. X.; Rui, C. H.; Fan, X. L.; Chen, F. H.; Wang, D.
Q. Synthesis and herbicidal activity of 12-(aryloxyacyloxyimino)-1,15-
pentadecanlactone derivatives. J. Agric. Food Chem. 2009, 57, 610−617.
(30) Schmidt, U.; Kubitzek, H. Synthesen mit den thioamiden der
(11) Judice, W. A. S.; Cezari, M. H. S.; Lima, A.; Scharfstein, J.;
Chagas, J. R.; Tersariol, I. L. S.; Juliano, M. A.; Juliano, L. Comparison
of the specificity, stability and individual rate constants with respective
activation parameters for the peptidase activity of Cruzipain and its
recombinant form, cruzain, from Trypanosoma cruzi. Eur. J. Biochem.
2001, 268, 6578−6586.
(12) Harth, G.; Andrews, N.; Mills, A. A.; Engel, J. C.; Smith, R.;
McKerrow, J. H. Peptide-fluromethyl ketones arrest intracellular
replication and intercellular transmission of Trypanosoma cruzi. Mol.
Biochem. Parasitol. 1993, 58, 17−24.
(13) Engel, J. C.; Doyle, P. S.; Hsieh, I.; McKerrow, J. H. Cysteine
protease inhibitors cure an experimental Trypanosoma cruzi infection.
J. Exp. Med. 1998, 188, 725−734.
(14) Barr, S. C.; Warner, K. L.; Kornreic, B. G.; Piscitelli, J.; Wolfe,
A.; Benet, L.; McKerrow, J. H. A cysteine protease inhibitor protects
dogs from cardiac damage during infection by Trypanosoma cruzi.
Antimicrob. Agents Chemother. 2005, 49, 5160−5161.
(15) Trossini, G. H. G.; Guido, R. V. C.; Oliva, G.; Ferreira, E. I.;
Andricopulo, A. D. Quantitative structure−activity relationships for a
series of inhibitors of cruzain from Trypanosoma cruzi: Molecular
modeling, CoMFA and CoMSIA studies. J. Mol. Graph. Model 2009,
28, 3−11.
(16) Guido, R.; Trossini, G.; Castilho, M.; Oliva, G.; Ferreira, E.;
Andricopulo, A. Structure−activity relationships for a class of selective
inhibitors of the major cysteine protease from Trypanosoma cruzi. J.
Enzym. Inhib. Med. Chem. 2008, 23, 964−973.
malonsaure, II thiopyridone aus cyan-thioacetamid. Chem. Ber. 1960,
̈
93, 1559−1565.
(31) Owsley, D. C.; Bloomfield, J. J. The reduction of nitroarenes
with iron/acetic acid. Synthesis 1977, 2, 118−120.
(32) Nestor, J. J.; Horner, B. L.; Ho, T. L.; Jones, G. H.; McRae, G. I.;
Vickery, B. H. Synthesis of a novel class of heteroaromatic amino acids
and their use in the preparation of analogues of luteinizing hormone-
releasing hormone. J. Med. Chem. 1984, 27, 320−325.
(33) The PyMOL Molecular Graphics System, Version 1.3;
Schrodinger, LLC, 2010.
̈
(34) Chen, Y. T.; Brinen, L. S.; Kerr, I. D.; Hansell, E.; Doyle, P. S.;
McKerrow, J. H.; Roush, W. R. In vitro and in vivo studies of the
trypanocidal properties of WRR-483 against Trypanosoma cruzi. PloS
Neglect. Trop. D 2010, 4, e825.
(35) Kerr, I. D.; Lee, J. H.; Farady, C. J.; Marion, R.; Rickert, M.;
Sajid, M.; Pandey, K. C.; Caffrey, C. R.; Legac, J.; Hansell, E.;
McKerrow, J. H.; Craik, C. S.; Rosenthal, P. J.; Brinen, L. S. Vinyl
sulfones as antiparasitic agents and a structural basis for drug design. J.
Biol. Chem. 2009, 284, 25697−25703.
(36) McKerrow, J. H. Development of cysteine protease inhibitors as
chemotherapy for parasitic diseases: Insights on safety, target
validation, and mechanism of action. Int. J. Parasitol. 1999, 29, 833−
837.
(37) Hopkins, A. L.; Groom, C. R.; Alex, A. Ligand efficiency: A
useful metric for lead selection. Drug Discov. Today 2004, 9, 430−431.
(38) Lipinski, C. A.; Lombardo, F.; Dominy, B. W.; Feeney, P. J.
Experimental and computational approaches to estimate solubility and
permeability in drug discovery and development settings. Adv. Drug
Delivery. Rev. 1997, 23, 3−25.
(39) Eakin, A. E.; McKerrow, J. H.; Fletterick, R. J.; Craik, C. S.
Production of crystallizable cruzain, the major cysteine protease from
Trypanosoma cruzi. J. Biol. Chem. 1993, 268, 6115−6118.
(40) Irwin, J. J.; Shoichet, B. K. ZINCA free database of
commercially available compounds for virtual screening. J. Chem. Inf.
Model. 2005, 45, 177−182.
(41) Verdonk, M. L.; Cole, J. C.; Hartshorn, M. J.; Murray, C. W.;
Taylor, R. D. Improved protein−ligand docking using GOLD. Proteins
2003, 52, 609−623.
(42) Verdonk, M. L.; Chessari, G.; Cole, J. C.; Hartshorn, M. J.;
Murray, C. W.; Nissink, J. W. M.; Taylor, R. D.; Taylor, R. Modeling
water molecules in protein-ligand docking using GOLD. J. Med. Chem.
2005, 48, 6504−6515.
(43) Buckner, F. S.; Verlinde, C. L.; La Flamme, A. C.; Van Voorhis,
W. C. Efficient technique for screening drugs for activity against
Trypanosoma cruzi using parasites expressing beta-galactosidase.
Antimicrob. Agents Chemother. 1996, 40, 2592−2597.
(17) Brak, K.; Doyle, P. S.; McKerrow, J. H.; Ellman, J. A.
Identification of a new class of nonpeptidic inhibitors of cruzain. J. Am.
Chem. Soc. 2008, 130, 6404−6410.
(18) Mott, B. T.; Ferreira, R. S.; Simeonov, A.; Jadhav, A.; Ang, K. K.
H.; Leister, W.; Shen, M.; Silveira, J. T.; Doyle, P. S.; Arkin, M. R.;
McKerrow, J. H.; Inglese, J.; Austin, C. P.; Thomas, C. J.; Shoichet, B.
K.; Maloney, D. J. Identification and optimization of inhibitors of
trypanosomal cysteine proteases: Cruzain, rhodesain, and TbCatB. J.
Med. Chem. 2010, 53, 52−60.
(19) Du, X. H.; Hansell, E.; Engel, J. C.; Caffrey, C. R.; Cohen, F. E.;
McKerrow, J. H. Aryl ureas represent a new class of anti-trypanosomal
agents. Chem. Biol. 2000, 7, 733−742.
(20) Ferreira, R. S.; Simeonov, A.; Jadhav, A.; Eidam, O.; Mott, B. T.;
Keiser, M. J.; McKerrow, J. H.; Maloney, D. J.; Irwin, J. J.; Shoichet, B.
K. Complementarity between a docking and a high-throughput screen
in discovering new cruzain inhibitors. J. Med. Chem. 2010, 53, 4891−
4905.
(21) Bryant, C.; Kerr, I. D.; Debnath, M.; Ang, K. K.; Ratnam, J.;
Ferreira, R. S.; Jaishankar, P.; Zhao, D.; Arkin, M. R.; McKerrow, J. H.;
Brinen, L. S.; Renslo, A. R. Novel non-peptidic vinylsulfones targeting
the S2 and S3 subsites of parasite cysteine proteases. Bioorg. Med.
Chem. Lett. 2009, 19, 6218−6221.
(22) Borchhardt, D. M.; Mascarello, A.; Chiaradia, L. D.; Nunes, R.
J.; Oliva, G.; Yunes, R. A.; Andricopulo, A. D. Biochemical evaluation
of a series of synthetic chalcone and hydrazide derivatives as novel
inhibitors of cruzain from Trypanosoma cruzi. J. Brazil. Chem. Soc.
2010, 21, 142−150.
(23) Brak, K.; Kerr, I. D.; Barrett, K. T.; Fuchi, N.; Debnath, M.; Ang,
K.; Engel, J. C.; McKerrow, J. H.; Doyle, P. S.; Brinen, L. S.; Ellman, J.
A. Nonpeptidic tetrafluorophenoxymethyl ketone cruzain inhibitors as
promising new leads for Chagas’ disease chemotherapy. J. Med. Chem.
2010, 53, 1763−1773.
(24) Huang, L.; Brinen, L. S.; Ellman, J. A. Crystal structures of
reversible ketone-based inhibitors of the cysteine protease cruzain.
Bioorg. Med. Chem. 2003, 11, 21−29.
(25) McGrath, M. E.; Eakin, A. E.; Engel, J. C.; McKerrow, J. H.;
Craik, C. S.; Fletterick, R. J. The crystal structure of cruzain: A
therapeutic target for Chagas’ disease. J. Mol. Biol. 1995, 247, 251−
259.
2392
dx.doi.org/10.1021/jm401709b | J. Med. Chem. 2014, 57, 2380−2392